We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Intuitive Surgical, Inc. (ISRG) Stock Falls Amid Market Uptick: What Investors Need to Know
Read MoreHide Full Article
Intuitive Surgical, Inc. (ISRG - Free Report) ended the recent trading session at $490.13, demonstrating a -0.7% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily gain of 0.79%. Elsewhere, the Dow saw an upswing of 0.78%, while the tech-heavy Nasdaq appreciated by 0.64%.
Shares of the company witnessed a gain of 1.89% over the previous month, beating the performance of the Medical sector with its loss of 8.97% and the S&P 500's loss of 3.56%.
The investment community will be closely monitoring the performance of Intuitive Surgical, Inc. in its forthcoming earnings report. The company is scheduled to release its earnings on April 22, 2025. The company is expected to report EPS of $1.71, up 14% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $2.18 billion, up 15.42% from the year-ago period.
ISRG's full-year Zacks Consensus Estimates are calling for earnings of $7.97 per share and revenue of $9.56 billion. These results would represent year-over-year changes of +8.58% and +14.42%, respectively.
Any recent changes to analyst estimates for Intuitive Surgical, Inc. should also be noted by investors. These recent revisions tend to reflect the evolving nature of short-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the company's business performance and profit potential.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.02% lower. Intuitive Surgical, Inc. is currently a Zacks Rank #3 (Hold).
Looking at its valuation, Intuitive Surgical, Inc. is holding a Forward P/E ratio of 61.91. This indicates a premium in contrast to its industry's Forward P/E of 24.12.
It's also important to note that ISRG currently trades at a PEG ratio of 3.84. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The average PEG ratio for the Medical - Instruments industry stood at 2.14 at the close of the market yesterday.
The Medical - Instruments industry is part of the Medical sector. This group has a Zacks Industry Rank of 78, putting it in the top 32% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Intuitive Surgical, Inc. (ISRG) Stock Falls Amid Market Uptick: What Investors Need to Know
Intuitive Surgical, Inc. (ISRG - Free Report) ended the recent trading session at $490.13, demonstrating a -0.7% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily gain of 0.79%. Elsewhere, the Dow saw an upswing of 0.78%, while the tech-heavy Nasdaq appreciated by 0.64%.
Shares of the company witnessed a gain of 1.89% over the previous month, beating the performance of the Medical sector with its loss of 8.97% and the S&P 500's loss of 3.56%.
The investment community will be closely monitoring the performance of Intuitive Surgical, Inc. in its forthcoming earnings report. The company is scheduled to release its earnings on April 22, 2025. The company is expected to report EPS of $1.71, up 14% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $2.18 billion, up 15.42% from the year-ago period.
ISRG's full-year Zacks Consensus Estimates are calling for earnings of $7.97 per share and revenue of $9.56 billion. These results would represent year-over-year changes of +8.58% and +14.42%, respectively.
Any recent changes to analyst estimates for Intuitive Surgical, Inc. should also be noted by investors. These recent revisions tend to reflect the evolving nature of short-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the company's business performance and profit potential.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.02% lower. Intuitive Surgical, Inc. is currently a Zacks Rank #3 (Hold).
Looking at its valuation, Intuitive Surgical, Inc. is holding a Forward P/E ratio of 61.91. This indicates a premium in contrast to its industry's Forward P/E of 24.12.
It's also important to note that ISRG currently trades at a PEG ratio of 3.84. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The average PEG ratio for the Medical - Instruments industry stood at 2.14 at the close of the market yesterday.
The Medical - Instruments industry is part of the Medical sector. This group has a Zacks Industry Rank of 78, putting it in the top 32% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.